Original Research
Published on 04 Oct 2022
in Molecular Innate Immunity
Original Research
Published on 10 Jun 2020
in Drugs Outcomes Research and Policies
Editorial
Published on 21 Apr 2023
in Analytical Chemistry
Original Research
Published on 09 Jan 2023
in Thoracic Oncology
Original Research
Published on 07 Jul 2020
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 18 May 2022
in Cancer Genetics
Original Research
Published on 10 Mar 2025
in Inflammation
Original Research
Published on 28 Jan 2025
in Integrative Bioinformatics
Original Research
Published on 12 Mar 2025
in Pharmacology of Anti-Cancer Drugs
Case Report
Published on 09 May 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 21 Sep 2021
in Molecular Diagnostics and Therapeutics
Original Research
Published on 16 Jul 2021
in Animal Nutrition and Metabolism
Review
Published on 27 Apr 2022
in Head and Neck Cancer
Review
Published on 28 Jan 2022
in Clinical and Diagnostic Microbiology and Immunology
Perspective
Published on 03 Jul 2025
in Connected Health
Review
Published on 29 Sep 2015
in Neurodegeneration
![“Rogue” neutrophil-subset [DEspR+CD11b+/CD66b+] immunotype is an actionable therapeutic target for neutrophilic inflammation-mediated tissue injury – studies in human, macaque and rat LPS-inflammation models](https://www.frontiersin.org/files/myhome article library/1008390/1008390_Thumb_400.jpg)
